Literature DB >> 16327963

A comparison of buccal midazolam and rectal diazepam for the acute treatment of seizures.

Sahika Baysun1, Omer Faruk Aydin, Emel Atmaca, Y K Yavuz Gürer.   

Abstract

In this study, the authors aimed to evaluate buccal midazolam as a practical and safe alternative medication for children who suffer from seizures in the emergency setting and in home practice or anywhere. The effects and side effects of buccal midazolam and rectal diazepam were compared in the treatment of acute convulsions in 43 children, ranging in age from 2 months to 12 years who were seen at the emergency service of the children hospital. Midazolam was given on the even days of the month and diazepam was given on the odd days. In the midazolam group, the seizures of 18/23 (78%) patients terminated in 10 minutes; however 5/23 (22%) patients did not respond. In the diazepam group 17/20 (85%) patients responded in 10 minutes, but 3/20 (15%) did not respond. Midazolam was found to be as effective as diazepam and the difference was not statistically significant (p<0.05). Response periods of the 2 drugs showed no significant difference (p>0.05). The need for a second drug for seizures that did not stop with the first drug was equal, and the difference was not statistically significant (p>0.05). They did not observe any serious complications. In conclusion, buccal midazolam is safe and as effective as rectal diazepam for the treatment of seizures. Clin Pediatr. 2005;44:771-776.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16327963     DOI: 10.1177/000992280504400904

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  17 in total

1.  Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society.

Authors:  Tracy Glauser; Shlomo Shinnar; David Gloss; Brian Alldredge; Ravindra Arya; Jacquelyn Bainbridge; Mary Bare; Thomas Bleck; W Edwin Dodson; Lisa Garrity; Andy Jagoda; Daniel Lowenstein; John Pellock; James Riviello; Edward Sloan; David M Treiman
Journal:  Epilepsy Curr       Date:  2016 Jan-Feb       Impact factor: 7.500

2.  Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis.

Authors:  Jason McMullan; Comilla Sasson; Arthur Pancioli; Robert Silbergleit
Journal:  Acad Emerg Med       Date:  2010-06       Impact factor: 3.451

3.  Efficacy of nonvenous medications for acute convulsive seizures: A network meta-analysis.

Authors:  Ravindra Arya; Harsh Kothari; Zongjun Zhang; Baoguang Han; Paul S Horn; Tracy A Glauser
Journal:  Neurology       Date:  2015-10-28       Impact factor: 9.910

Review 4.  A Common Reference-Based Indirect Comparison Meta-Analysis of Buccal versus Intranasal Midazolam for Early Status Epilepticus.

Authors:  Francesco Brigo; Raffaele Nardone; Frediano Tezzon; Eugen Trinka
Journal:  CNS Drugs       Date:  2015-09       Impact factor: 5.749

Review 5.  Oromucosal midazolam: a review of its use in pediatric patients with prolonged acute convulsive seizures.

Authors:  Karly P Garnock-Jones
Journal:  Paediatr Drugs       Date:  2012-08-01       Impact factor: 3.022

6.  Guidelines for the evaluation and management of status epilepticus.

Authors:  Gretchen M Brophy; Rodney Bell; Jan Claassen; Brian Alldredge; Thomas P Bleck; Tracy Glauser; Suzette M Laroche; James J Riviello; Lori Shutter; Michael R Sperling; David M Treiman; Paul M Vespa
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

Review 7.  Treatment of Generalized Convulsive Status Epilepticus in Pediatric Patients.

Authors:  Elizabeth L Alford; James W Wheless; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jul-Aug

Review 8.  New Non-Intravenous Routes for Benzodiazepines in Epilepsy: A Clinician Perspective.

Authors:  Marco Mula
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

9.  Predictors of anti-convulsant treatment failure in children presenting with malaria and prolonged seizures in Kampala, Uganda.

Authors:  Arthur Mpimbaza; Sarah G Staedke; Grace Ndeezi; Justus Byarugaba; Philip J Rosenthal
Journal:  Malar J       Date:  2009-06-29       Impact factor: 2.979

10.  Oromucosal midazolam: a guide to its use in paediatric patients with prolonged acute convulsive seizures.

Authors:  Lesley J Scott; Katherine A Lyseng-Williamson; Karly P Garnock-Jones
Journal:  CNS Drugs       Date:  2012-10-01       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.